Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hemorrhage × Dalteparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism 1 Thrombocytopenia 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hemorrhage 1

Interventions

Tranexamic Acid 2 Misoprostol 2 carbetocin 1 Vitamin B 6 1 Vasopressins 1 Uterine Artery Embolization 1 Tourniquets 1 Terlipressin 1 Sodium Chloride 1 Sensitivity Training Groups 1 Rivaroxaban 1 Oxytocin 1 Ibuprofen 1 Ethamsylate 1 Enoxaparin 1 Dalteparin 1 Bupivacaine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01741506 2015-06-23

COPPVATS

Aarhus University Hospital

Phase 4 Completed

Hemorrhage, Lung Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡